Daclatasvir dihydrochloride(also known as BMS790052 dihydrochloride) is a potent inhibitor of HCV NS5A (nonstructural protein 5A).
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
NS5A Inhibitors Impair NS5A–Phosphatidylinositol 4-Kinase IIIα Complex Formation and Cause a Decrease of Phosphatidylinositol 4-Phosphate and Cholesterol Levels in Hepatitis C Virus-Associated Membranes.
Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity.
 M.Gao, et al, Nature, 2010, 465(7294), pp 96-100.